Skip to main content
. 2018 Apr 13;9(28):19980–19993. doi: 10.18632/oncotarget.25007

Table 3. Correlation between AR expression and clinical features.

Clinical features Statistical test and results
Days to death or last follow up Logrank P=0.787 Q = 0.920
Years to birth Spearman Correlation R=0.1105 P=0.01132 Q = 0.0765
Gender Wilcoxon test P = 0.8432 Q= 0.971
Radiation therapy Wilcoxon test P = 0.895 Q= 0.98
Karnofsky performance score Spearman Correlation R= -0.0978 P= 0.05173 Q= 0.324
Race Kruskal wallis P =0.2541 Q=1
Ethnicity Wilcoxon test P = 0.351 Q= 0.952

Significance (bold) when P value < 0.05 and Q value (False Discovery Rate) < 0.3.

A table drawn from the analysis made by the Broad Institute TCGA Genome Data Analysis Center [11] showing the results of the association between the clinical features and AR expression across 519 tumor samples according to the statistical methods used.